The global HLA Typing for Transplant Market was valued at USD 533.78 million in 2016 and is projected to reach USD 970.65 million by 2025, growing at a CAGR of 6.87% from 2017 to 2025.
Human leukocyte antigen (HLA) typing is used to match patients and donors for bone marrow or cord blood transplants. Due to increasing transplant failures there is a rising need to match the organ transplant feasibility before the surgery to avoid any kind of loss. There are increasing fund in the HLA Typing market from the side of Govt. as well as Pvt. Sector.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Growing number of Tissue and Organ transplantations
1.2 Growing technical support and discoveries in HLA Typing
1.3 Growing Funds from both Government and Private sector
2. Market Restraints
2.1 High technology associated costs
2.2 Limited reimbursements
2.3 High cost of techniques like PCR
Market Segmentation:
1. Global HLA Typing for Transplant Market, by Applications:
1.1 Research applications
1.2 Diagnostic Applications
2. Global HLA Typing for Transplant Market, by Products and Services:
2.1 Reagents and Consumables
2.2 Software and Services
2.3 Instruments
3. Global HLA Typing for Transplant Market, by End User:
3.1 Commercial Service Providers
3.2 Research Laboratories and Academic Institutes
3.3 Hospitals and Transplant Centers
4. Global HLA Typing for Transplant Market, by Technology:
4.1 Non Molecular Assays
4.1.1 Mixed Lymphocyte Culture (MLC) Assays
4.1.2 Serological Assays
4.2 Molecular Assays
4.2.1 Sequencing Based
4.2.1.1 Next-Generation Sequencing (NGS)
4.2.1.2 Sanger Sequencing
4.2.2 PCR Based
4.2.2.1 Sequence-Specific Oligonucleotide (SSO)-PCR
4.2.2.2 Sequence-Specific Primer (SSP)-PCR
5. Global HLA Typing for Transplant Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific, Inc.
2. Immucor, Inc.
3. Olerup SSP AB
4. Qiagen N.V.
5. Bio-Rad Laboratories, Inc.
6. Illumina, Inc.
7. Affymetrix, Inc.
8. F. Hoffmann-LA-Roche Limited
9. Luminex Corporation
10. Abbott Laboratories, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the HLA Typing for Transplant Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL HLA TYPING FOR TRANSPLANT MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL HLA TYPING FOR TRANSPLANT MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 Global HLA Typing for Transplant Market, by Applications:
5.1 Research applications
5.2 Diagnostic Applications
6 Global HLA Typing for Transplant Market, by Products and Services:
6.1 Reagents and Consumables
6.2 Software and Services
6.3 Instruments
7 Global HLA Typing for Transplant Market, by End User:
7.1 Commercial Service Providers
7.2 Research Laboratories and Academic Institutes
7.3 Hospitals and Transplant Centers
8 Global HLA Typing for Transplant Market, by Technology:
8.1 Non Molecular Assays
8.1.1 Mixed Lymphocyte Culture (MLC) Assays
8.1.2 Serological Assays
8.2 Molecular Assays
8.2.1 Sequencing Based
8.2.1.1 Next-Generation Sequencing (NGS)
8.2.1.2 Sanger Sequencing
8.2.2 PCR Based
8.2.2.1 Sequence-Specific Oligonucleotide (SSO)-PCR
8.2.2.2 Sequence-Specific Primer (SSP)-PCR
9 GLOBAL HLA TYPING FOR TRANSPLANT MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
10 GLOBAL HLA TYPING FOR TRANSPLANT MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Immucor, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Olerup SSP AB
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Qiagen N.V.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Illumina, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Affymetrix, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 F. Hoffmann-LA-Roche Limited
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Luminex Corporation
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Abbott Laboratories, Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports
Overview of the Global Typing Software for Kids Market:
The report discusses everything a marketer requires before investing in the global Typing Software for Kids Market during the forecast period 2023-2030. It pro...
Overview of the Global Organ Transplant Transportation Services Market:
The report discusses everything a marketer requires before investing in the global Organ Transplant Transportation Services Market during the f...
Overview of the Global Beard Transplant Services Market:
The report discusses everything a marketer requires before investing in the global Beard Transplant Services Market during the forecast period 2023-2030. It p...
The global Organ Transplant Immunosuppressant market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market p...
The global Cell Transplant market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fiel...
The global Organ Transplant Diagnostics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players...
The global Bone Marrow Transplant market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in th...
The global HLA Typing Transplant market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in thi...
Overview of the Global Transplant Complications Drug Development Market:
The report discusses everything a marketer requires before investing in the global Transplant Complications Drug Development Market during the...
Overview of the Global Fecal Transplant Therapy Market:
The report discusses everything a marketer requires before investing in the global Fecal Transplant Therapy Market during the forecast period 2023-2030. It pro...